What Next for Imperva Incorporated (NASDAQ:IMPV) Stock After Increase in Shorted Shares?

February 14, 2018 - By Winifred Garcia

 What Next for Imperva Incorporated (NASDAQ:IMPV) Stock After Increase in Shorted Shares?

Investors sentiment decreased to 1.43 in 2017 Q3. Its down 0.17, from 1.6 in 2017Q2. It turned negative, as 24 investors sold Imperva, Inc. shares while 39 reduced holdings. 29 funds opened positions while 61 raised stakes. 29.31 million shares or 0.63% more from 29.13 million shares in 2017Q2 were reported.
Envestnet Asset holds 0% of its portfolio in Imperva, Inc. (NASDAQ:IMPV) for 683 shares. Pacad invested in 0.02% or 2,500 shares. First Republic Investment Mgmt Inc has invested 0% in Imperva, Inc. (NASDAQ:IMPV). 2,940 were reported by Ameritas Invest Prns. Fuller And Thaler Asset Mngmt Inc, California-based fund reported 180,760 shares. Natl Bank Of Montreal Can has invested 0% in Imperva, Inc. (NASDAQ:IMPV). Mirae Asset Glob Invests Ltd invested 0.02% in Imperva, Inc. (NASDAQ:IMPV). Morgan Stanley invested in 0% or 240,950 shares. Jacobs Levy Equity holds 118,101 shares or 0.1% of its portfolio. Federated Invsts Pa reported 10,872 shares or 0% of all its holdings. Artemis Invest Limited Liability Partnership invested 0.05% in Imperva, Inc. (NASDAQ:IMPV). Tudor Invest Et Al stated it has 23,303 shares or 0.03% of all its holdings. Wells Fargo & Co Mn invested in 0% or 213,953 shares. Prelude Cap Mgmt Limited Liability Company, a New York-based fund reported 4,291 shares. Moreover, Eagle Asset Incorporated has 0.32% invested in Imperva, Inc. (NASDAQ:IMPV) for 1.29 million shares.

The stock of Imperva Incorporated (NASDAQ:IMPV) registered an increase of 2.21% in short interest. IMPV’s total short interest was 2.01 million shares in February as published by FINRA. Its up 2.21% from 1.96 million shares, reported previously. With 236,900 shares average volume, it will take short sellers 9 days to cover their IMPV’s short positions. The short interest to Imperva Incorporated’s float is 7.88%.

The stock increased 0.22% or $0.1 during the last trading session, reaching $46. About 857,906 shares traded or 164.12% up from the average. Imperva, Inc. (NASDAQ:IMPV) has risen 38.26% since February 14, 2017 and is uptrending. It has outperformed by 21.56% the S&P500.

Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company has market cap of $1.57 billion. The companyÂ’s SecureSphere product line provides database, file, and Web application security in various data centers, including on-premise data centers, as well as private, public, and hybrid cloud computing environments. It has a 168.5 P/E ratio. The Company’s SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management.

More notable recent Imperva, Inc. (NASDAQ:IMPV) news were published by: Nasdaq.com which released: “Earnings Reaction History: Imperva Inc, 66.7% Follow-Through Indicator, 10.0 …” on January 25, 2018, also Businesswire.com with their article: “Imperva Protects NetRefer Website and Customers From Cyberattacks” published on February 13, 2018, Seekingalpha.com published: “Imperva: The Value-Destructive Effects Of Dilution” on January 31, 2018. More interesting news about Imperva, Inc. (NASDAQ:IMPV) were released by: Businesswire.com and their article: “Imperva Announces Fourth Quarter and Full Year 2017 Financial Results” published on February 08, 2018 as well as Seekingalpha.com‘s news article titled: “Imperva reports Q4 EPS beat, downside revenue guidance” with publication date: February 09, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: